aspirin has been researched along with trimetazidine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Aleksandriia, LG; Moiseev, VS; Tereshchenko, SN | 1 |
| Efimova, I; Filippov, EA; Garganeeva, AA; Kaliuzhin, VV; Pushnikova, EIu; Sankevich, qV; Stepacheva, TA; Tepliakov, AT; Zavadovskiĭ, KV | 1 |
| Fischer, T | 2 |
| Han, X; Jing, Q; Li, R; Tang, X; Wang, Q; Yang, M; Yu, X; Zhao, J | 1 |
2 review(s) available for aspirin and trimetazidine
| Article | Year |
|---|---|
[New possibilities in the pharmacologic prevention of age-related macular degeneration].
Topics: Adrenergic Antagonists; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cardiovascular Agents; Endothelium, Vascular; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Macular Degeneration; Oxidative Stress; Platelet Aggregation Inhibitors; Primary Prevention; Risk Factors; Trimetazidine; Vasodilation; Vasodilator Agents | 2008 |
[Pharmacological therapy of age-related macular degeneration based on etiopathogenesis].
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Aspirin; Bosentan; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Folic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infliximab; Lutein; Macular Degeneration; Melatonin; PPAR gamma; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Resveratrol; Stilbenes; Sulfonamides; Trimetazidine; Tumor Necrosis Factor-alpha; Ubiquinone; Vitamin D; Xanthophylls | 2015 |
3 trial(s) available for aspirin and trimetazidine
| Article | Year |
|---|---|
[Use of trimetazidine in the combined therapy of myocardial infarction with left ventricular dysfunction].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Diuretics; Drug Therapy, Combination; Echocardiography; Echocardiography, Doppler; Female; Fibrinolytic Agents; Follow-Up Studies; Hemodynamics; Heparin; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Platelet Aggregation Inhibitors; Thrombolytic Therapy; Time Factors; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Remodeling | 2002 |
[Anti-ischemic effects of trimetazidine in patients with post-infarction heart failure].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Trimetazidine; Vasodilator Agents | 2004 |
The effect of trimetazidine treatment in patients with type 2 diabetes undergoing percutaneous coronary intervention for AMI.
Topics: Adenosine; Aged; Alanine Transaminase; Aspartate Aminotransferases; Aspirin; Blood Glucose; Cardiac Output; China; Creatine Kinase; Creatine Kinase, MB Form; Creatinine; Diabetes Mellitus, Type 2; Echocardiography; Female; Glycated Hemoglobin; Heart Atria; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Stroke Volume; Ticagrelor; Treatment Outcome; Trimetazidine; Troponin I; Urea; Vasodilator Agents | 2017 |
1 other study(ies) available for aspirin and trimetazidine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |